Bellevue Group’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-431,070
| Closed | -$8.12M | – | 164 |
|
|
2025
Q4 | $8.12M | Sell |
431,070
-141,886
| -25% | -$2.38M | 0.15% | 67 |
|
|
2025
Q3 | $8.33M | Sell |
572,956
-179,415
| -24% | -$2.56M | 0.17% | 66 |
|
|
2025
Q2 | $14.7M | Sell |
752,371
-136,632
| -15% | -$2.43M | 0.32% | 56 |
|
|
2025
Q1 | $15.8M | Sell |
889,003
-485,409
| -35% | -$10.5M | 0.35% | 57 |
|
|
2024
Q4 | $29.4M | Sell |
1,374,412
-1,771,044
| -56% | -$43.1M | 0.57% | 44 |
|
|
2024
Q3 | $98.2M | Sell |
3,145,456
-767,119
| -20% | -$19.1M | 1.59% | 19 |
|
|
2024
Q2 | $60.8M | Sell |
3,912,575
-21,431
| -0.5% | -$259K | 0.99% | 26 |
|
|
2024
Q1 | $41.7M | Sell |
3,934,006
-20,786
| -0.5% | -$208K | 0.64% | 50 |
|
|
2023
Q4 | $47.5M | Buy |
3,954,792
+13,994
| +0.4% | +$115K | 0.73% | 44 |
|
|
2023
Q3 | $27.6M | Buy |
3,940,798
+224,321
| +6% | +$2.07M | 0.44% | 65 |
|
|
2023
Q2 | $31.6M | Buy |
3,716,477
+277,386
| +8% | +$2.31M | 0.45% | 64 |
|
|
2023
Q1 | $31.4M | Buy |
3,439,091
+270,643
| +9% | +$3.46M | 0.46% | 61 |
|
|
2022
Q4 | $36.2M | Buy |
3,168,448
+567,002
| +22% | +$8.4M | 0.48% | 62 |
|
|
2022
Q3 | $44.3M | Buy |
2,601,446
+63,922
| +3% | +$1.37M | 0.64% | 47 |
|
|
2022
Q2 | $54.5M | Buy |
2,537,524
+226,348
| +10% | +$6.28M | 0.77% | 44 |
|
|
2022
Q1 | $85.5M | Buy |
2,311,176
+844,624
| +58% | +$32.9M | 0.99% | 34 |
|
|
2021
Q4 | $66.7M | Buy |
1,466,552
+1,435,609
| +4,640% | +$74.9M | 0.69% | 50 |
|
|
2021
Q3 | $1.96M | Sell |
30,943
-117,928
| -79% | -$8.98M | 0.02% | 148 |
|
|
2021
Q2 | $13.6M | Sell |
148,871
-41,500
| -22% | -$3.3M | 0.13% | 119 |
|
|
2021
Q1 | $13M | Sell |
190,371
-153,612
| -45% | -$11.9M | 0.14% | 114 |
|
|
2020
Q4 | $24.9M | Sell |
343,983
-771,920
| -69% | -$44.7M | 0.29% | 89 |
|
|
2020
Q3 | $42.3M | Sell |
1,115,903
-50,936
| -4% | -$1.72M | 0.59% | 50 |
|
|
2020
Q2 | $41.3M | Sell |
1,166,839
-110,212
| -9% | -$3.14M | 0.59% | 46 |
|
|
2020
Q1 | $27.9M | Buy |
1,277,051
+100,321
| +9% | +$2.25M | 0.54% | 49 |
|
|
2019
Q4 | $25.4M | Buy |
1,176,730
+454,075
| +63% | +$10.4M | 0.4% | 55 |
|
|
2019
Q3 | $16.3M | Buy |
722,655
+230,647
| +47% | +$6.39M | 0.3% | 67 |
|
|
2019
Q2 | $17.7M | Buy |
492,008
+60,440
| +14% | +$1.93M | 0.3% | 60 |
|
|
2019
Q1 | $13.6M | Sell |
431,568
-104,920
| -20% | -$3.06M | 0.75% | 45 |
|
|
2018
Q4 | $13.5M | Buy |
536,488
+199,439
| +59% | +$5.12M | 0.89% | 35 |
|
|
2018
Q3 | $9.72M | Buy |
+337,049
| New | +$6.31M | 0.62% | 52 |
|
Other funds holding CDNA
AIM
DM
B
VCM
GS
